Postmortem genetic diagnosis of hereditary leiomyomatosis and renal cell carcinoma syndrome: Identification through normal kidney tissues after surgical removal
This highlights the utility of postmortem genetic testing of surgical specimens to diagnose hereditary leiomyomatosis and renal cell cancer and provide genetic counseling to families, despite limitations during the patient's life.
Authors
- Kae Hashimoto (ORCID: https://orcid.org/0000-0002-5836-9359)
- Yoshiyuki Yamamoto (ORCID: https://orcid.org/0000-0002-1271-3521)
- Koji Hatano (ORCID: https://orcid.org/0000-0002-8409-5152)
- Atsunari Kawashima (ORCID: https://orcid.org/0000-0001-9369-4264)
- Yoji Nagashima (ORCID: https://orcid.org/0000-0002-6536-648X)
- Takako Miyamura (ORCID: https://orcid.org/0000-0002-3226-556X)
- Takahiro Matsui (ORCID: https://orcid.org/0000-0002-6753-1688)
- Suguru SUZUKI (ORCID: https://orcid.org/0000-0002-0141-7428)
- Taigo Kato (ORCID: https://orcid.org/0000-0002-8681-1407)
- Norio Nonomura (ORCID: https://orcid.org/0000-0002-6522-6233)
Institutions
- Tokyo Women's Medical University Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1002/iju5.12820
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00